Published in Am J Physiol Lung Cell Mol Physiol on March 23, 2017
The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol (2005) 2.39
Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol (2009) 2.26
Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem (1998) 2.24
Lysosomal disorders: from storage to cellular damage. Biochim Biophys Acta (2008) 2.22
Store-operated Ca2+ entry in porcine airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2003) 1.96
Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest (2006) 1.91
The cellular and molecular basis of bitter tastant-induced bronchodilation. PLoS Biol (2013) 1.85
Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res (2006) 1.69
Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A (2009) 1.67
Pompe disease: design, methodology, and early findings from the Pompe Registry. Mol Genet Metab (2011) 1.48
Increased aortic stiffness and blood pressure in non-classic Pompe disease. J Inherit Metab Dis (2014) 1.44
Regulation of airway smooth muscle cell contractility by Ca2+ signaling and sensitivity. Proc Am Thorac Soc (2008) 1.41
Pompe disease gene therapy. Hum Mol Genet (2011) 1.39
Dynamics of signaling between Ca(2+) sparks and Ca(2+)- activated K(+) channels studied with a novel image-based method for direct intracellular measurement of ryanodine receptor Ca(2+) current. J Gen Physiol (2000) 1.37
Adult-onset acid maltase deficiency: a postmortem study. Muscle Nerve (1979) 1.33
Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors. Mol Ther (2007) 1.31
Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium (2011) 1.30
The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve (1987) 1.25
Airway smooth muscle in airway reactivity and remodeling: what have we learned? Am J Physiol Lung Cell Mol Physiol (2013) 1.23
Ca(2+) homeostasis and structural and functional remodelling of airway smooth muscle in asthma. Thorax (2010) 1.22
Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes. Hum Gene Ther (2013) 1.19
Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice. J Neuropathol Exp Neurol (2008) 1.19
High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology. J Histochem Cytochem (2005) 1.16
Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature. Mol Genet Metab (2012) 1.13
Hypoglossal neuropathology and respiratory activity in pompe mice. Front Physiol (2011) 1.10
The respiratory neuromuscular system in Pompe disease. Respir Physiol Neurobiol (2013) 1.09
Contractility and Ca2+ signaling of smooth muscle cells in different generations of mouse airways. Am J Respir Cell Mol Biol (2006) 1.08
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma. Respir Med (2008) 1.07
Ion channel regulation of intracellular calcium and airway smooth muscle function. Pulm Pharmacol Ther (2008) 1.01
Infantile acid maltase deficiency. I. Muscle fiber destruction after lysosomal rupture. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 1.00
Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency. J Neurol Sci (1990) 0.99
Obstructive sleep apnea syndrome in acid maltase deficiency. Chest (1994) 0.98
Effects of formoterol on contraction and Ca2+ signaling of mouse airway smooth muscle cells. Am J Respir Cell Mol Biol (2009) 0.98
Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered. Mol Genet Metab (2011) 0.98
Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation. Muscle Nerve (2011) 0.97
Cyclic nucleotide regulation of store-operated Ca2+ influx in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2005) 0.97
Evaluation of respiratory system mechanics in mice using the forced oscillation technique. J Vis Exp (2013) 0.96
Infantile onset Pompe disease: a report of physician narratives from an epidemiologic study. Genet Med (2005) 0.95
Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe's disease). Neurosurgery (1987) 0.95
The transmembrane protein 16A Ca(2+)-activated Cl- channel in airway smooth muscle contributes to airway hyperresponsiveness. Am J Respir Crit Care Med (2012) 0.93
Effects of three different L-type Ca2+ entry blockers on airway constriction induced by muscarinic receptor stimulation. Br J Anaesth (2003) 0.91
Store-operated Ca2+ influx in airway smooth muscle: Interactions between volatile anesthetic and cyclic nucleotide effects. Anesthesiology (2006) 0.91
Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice. Mol Ther (2013) 0.90
Excitation-contraction coupling in airway smooth muscle. J Biol Chem (2006) 0.90
Pompe disease and physical disability. Dev Med Child Neurol (2003) 0.90
Paediatric Tracheomalacia. Paediatr Respir Rev (2015) 0.90
The reverse mode of the Na(+)/Ca(2+) exchanger provides a source of Ca(2+) for store refilling following agonist-induced Ca(2+) mobilization. Am J Physiol Lung Cell Mol Physiol (2006) 0.89
Effects of salbutamol on intracellular calcium oscillations in porcine airway smooth muscle. J Appl Physiol (1985) (1997) 0.88
Promoting effects of IL-13 on Ca2+ release and store-operated Ca2+ entry in airway smooth muscle cells. Pulm Pharmacol Ther (2010) 0.88
Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease. Autophagy (2015) 0.87
Ocular and histologic findings in a series of children with infantile pompe disease treated with enzyme replacement therapy. J Pediatr Ophthalmol Strabismus (2014) 0.85
Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy. Pharmacol Ther (2015) 0.83
Stroke in Young-Dilative Arteriopathy: A Clue to Late-Onset Pompe's Disease? J Stroke Cerebrovasc Dis (2016) 0.81
Ptosis as a feature of late-onset glycogenosis type II. Neurology (2007) 0.80
Store-operated calcium entry is required for sustained contraction and Ca(2+) oscillations of airway smooth muscle. J Physiol (2016) 0.80
Expanding our understanding of lower urinary tract symptoms and incontinence in adults with pompe disease. JIMD Rep (2015) 0.79
Adult-onset acid maltase deficiency in siblings. Acta Pathol Jpn (1985) 0.79
Late-onset Pompe disease with left-sided bronchomalacia. Respir Care (2014) 0.79
Resting calcium influx in airway smooth muscle. Can J Physiol Pharmacol (2005) 0.78
Pompe disease: Shared and unshared features of lysosomal storage disorders. Rare Dis (2015) 0.77
Diaphragm Pacing as a Rehabilitative Tool for Patients With Pompe Disease Who Are Ventilator-Dependent: Case Series. Phys Ther (2016) 0.77
Delivered dose estimate to standardize airway hyperresponsiveness assessment in mice. Am J Physiol Lung Cell Mol Physiol (2015) 0.77
Involvement of Ca2+ mobilization in tachyphylaxis to beta-adrenergic receptors in trachealis. Am J Respir Cell Mol Biol (2003) 0.76
Management of Life-Threatening Tracheal Stenosis and Tracheomalacia in Patients with Mucopolysaccharidoses. JIMD Rep (2016) 0.75
Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease. JIMD Rep (2015) 0.75
The RyR-Cl -VDCC axis contributes to spontaneous tone in urethral smooth muscle. J Cell Physiol (2019) 0.75